Well-Intentioned, But Can The Improved AAC Work For UK Medtechs?

The newly enhanced Accelerated Access Collaborative (AAC) promises a more concerted effort to ensure health-care innovations reach end users. On paper, it looks good, but the medtech industry in the UK has seen several worthy efforts along similar lines ultimately amount to little. Health Enterprise East’s Dr. Anne Blackwood is reserving judgment.

Innovative idea solution concept and new thinking business symbol as a light bulb breaking through a maze or labyrinth as an icon for innovation and invention. - Illustration

The improvements to NHS England’s Accelerated Access Collaborative (AAC), announced last week, are designed to put the most promising devices, diagnostic tools, digital services and medicines through clinical development and regulatory approval processes faster.

The AAC will act as the umbrella organization for UK health technology innovation. (Also see "UK Plan To Speed Access To ‘Cutting-Edge’ Products" - Medtech Insight, 2 May, 2019.)...

More from United Kingdom

More from Europe